<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1990-01-01" modified="2020-10-07" version="218">
<accession>P13688</accession>
<accession>A6NE38</accession>
<accession>A8MY49</accession>
<accession>O60430</accession>
<accession>Q069I7</accession>
<accession>Q13854</accession>
<accession>Q13857</accession>
<accession>Q13858</accession>
<accession>Q13859</accession>
<accession>Q13860</accession>
<accession>Q15600</accession>
<accession>Q15601</accession>
<accession>Q16170</accession>
<accession>Q5UB49</accession>
<accession>Q7KYP5</accession>
<accession>Q96CA7</accession>
<accession>Q9UQV9</accession>
<name>CEAM1_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="34">Carcinoembryonic antigen-related cell adhesion molecule 1</fullName>
</recommendedName>
<alternativeName>
<fullName evidence="30">Biliary glycoprotein 1</fullName>
<shortName>BGP-1</shortName>
</alternativeName>
<cdAntigenName>CD66a</cdAntigenName>
</protein>
<gene>
<name type="primary" evidence="36">CEACAM1</name>
<name type="synonym" evidence="33">BGP</name>
<name type="synonym">BGP1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1989" name="J. Cell Biol." volume="108" first="267" last="276">
<title>Carcinoembryonic antigens: alternative splicing accounts for the multiple mRNAs that code for novel members of the carcinoembryonic antigen family.</title>
<authorList>
<person name="Barnett T.R."/>
<person name="Kretschmer A."/>
<person name="Austen D.A."/>
<person name="Goebel S.J."/>
<person name="Hart J.T."/>
<person name="Elting J.J."/>
<person name="Kamarck M.E."/>
</authorList>
<dbReference type="PubMed" id="2537311"/>
<dbReference type="DOI" id="10.1083/jcb.108.2.267"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 6 AND 8)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1988" name="Proc. Natl. Acad. Sci. U.S.A." volume="85" first="6959" last="6963">
<title>Molecular cloning of a cDNA coding biliary glycoprotein I: primary structure of a glycoprotein immunologically crossreactive with carcinoembryonic antigen.</title>
<authorList>
<person name="Hinoda Y."/>
<person name="Neumaier M."/>
<person name="Hefta S.A."/>
<person name="Drzeniek Z."/>
<person name="Wagener C."/>
<person name="Shively L."/>
<person name="Hefta L.J.F."/>
<person name="Shively J.E."/>
<person name="Paxton R.J."/>
</authorList>
<dbReference type="PubMed" id="2457922"/>
<dbReference type="DOI" id="10.1073/pnas.85.18.6959"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>PYROGLUTAMATE FORMATION AT GLN-35</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1989" name="Proc. Natl. Acad. Sci. U.S.A." volume="86" first="1668" last="1668">
<authorList>
<person name="Hinoda Y."/>
<person name="Neumaier M."/>
<person name="Hefta S.A."/>
<person name="Drzeniek Z."/>
<person name="Wagener C."/>
<person name="Shively L."/>
<person name="Hefta L.J.F."/>
<person name="Shively J.E."/>
<person name="Paxton R.J."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:2457922</scope>
<scope>SEQUENCE REVISION</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1991" name="Biochem. Biophys. Res. Commun." volume="176" first="578" last="585">
<title>Three novel molecular forms of biliary glycoprotein deduced from cDNA clones from a human leukocyte library.</title>
<authorList>
<person name="Kuroki M."/>
<person name="Arakawa F."/>
<person name="Matsuo Y."/>
<person name="Oikawa S."/>
<person name="Nakazato H."/>
<person name="Matsuoka Y."/>
</authorList>
<dbReference type="PubMed" id="2025273"/>
<dbReference type="DOI" id="10.1016/s0006-291x(05)80223-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>GLYCOSYLATION</scope>
<source>
<tissue>Leukocyte</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="1992-06" db="EMBL/GenBank/DDBJ databases">
<title>A new isoform of human biliary glycoprotein (BGP) containing a domain encoded by an Alu-like sequence.</title>
<authorList>
<person name="Kuroki M."/>
<person name="Matsuo Y."/>
<person name="Misumi Y."/>
<person name="Oikawa S."/>
<person name="Matsuoka Y."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)</scope>
<source>
<tissue>Monocyte</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1993" name="Mol. Cell. Biol." volume="13" first="1273" last="1282">
<title>Human biliary glycoprotein gene: characterization of a family of novel alternatively spliced RNAs and their expressed proteins.</title>
<authorList>
<person name="Barnett T.R."/>
<person name="Drake L."/>
<person name="Pickle W. II"/>
</authorList>
<dbReference type="PubMed" id="8423792"/>
<dbReference type="DOI" id="10.1128/mcb.13.2.1273"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7)</scope>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 293-494 (ISOFORM 5)</scope>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 293-458 (ISOFORM 9)</scope>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 293-458</scope>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1994" name="Blood" volume="84" first="200" last="210">
<title>CD66 identifies the biliary glycoprotein (BGP) adhesion molecule: cloning, expression, and adhesion functions of the BGPc splice variant.</title>
<authorList>
<person name="Watt S.M."/>
<person name="Fawcett J."/>
<person name="Murdoch S.J."/>
<person name="Teixeira A.M."/>
<person name="Gschmeissner S.E."/>
<person name="Hajibagheri N.M."/>
<person name="Simmons D.L."/>
</authorList>
<dbReference type="PubMed" id="8018919"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 8)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<tissue>Colon adenocarcinoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="submission" date="2004-09" db="EMBL/GenBank/DDBJ databases">
<title>Isolation of the cDNA encoding a putative carcinoembryonic antigen-related cell adhesion molecule 1 short form 3 (CEACAM1-3S).</title>
<authorList>
<person name="Long S."/>
<person name="Phillips A."/>
<person name="Ma H."/>
<person name="Paoni N.F."/>
<person name="Wong-Staal F."/>
<person name="Fan W."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 11)</scope>
</reference>
<reference key="9">
<citation type="submission" date="2006-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS LYS-35; VAL-83; HIS-123 AND ARG-376</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Nature" volume="428" first="529" last="535">
<title>The DNA sequence and biology of human chromosome 19.</title>
<authorList>
<person name="Grimwood J."/>
<person name="Gordon L.A."/>
<person name="Olsen A.S."/>
<person name="Terry A."/>
<person name="Schmutz J."/>
<person name="Lamerdin J.E."/>
<person name="Hellsten U."/>
<person name="Goodstein D."/>
<person name="Couronne O."/>
<person name="Tran-Gyamfi M."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Ashworth L."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caenepeel S."/>
<person name="Carrano A.V."/>
<person name="Caoile C."/>
<person name="Chan Y.M."/>
<person name="Christensen M."/>
<person name="Cleland C.A."/>
<person name="Copeland A."/>
<person name="Dalin E."/>
<person name="Dehal P."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Garcia C."/>
<person name="Georgescu A.M."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Ho I."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Larionov V."/>
<person name="Leem S.-H."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Malfatti S."/>
<person name="Martinez D."/>
<person name="McCready P.M."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nelson K."/>
<person name="Nolan M."/>
<person name="Ovcharenko I."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Popkie A.P."/>
<person name="Predki P."/>
<person name="Quan G."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="She X."/>
<person name="Smith D."/>
<person name="Slezak T."/>
<person name="Solovyev V."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wagner M."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Xie G."/>
<person name="Yang J."/>
<person name="Dubchak I."/>
<person name="Furey T.S."/>
<person name="DeJong P."/>
<person name="Dickson M."/>
<person name="Gordon D."/>
<person name="Eichler E.E."/>
<person name="Pennacchio L.A."/>
<person name="Richardson P."/>
<person name="Stubbs L."/>
<person name="Rokhsar D.S."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Lucas S.M."/>
</authorList>
<dbReference type="PubMed" id="15057824"/>
<dbReference type="DOI" id="10.1038/nature02399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="11">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 10)</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="1994" name="Eur. J. Biochem." volume="223" first="529" last="541">
<title>Transcriptional control of the human biliary glycoprotein gene, a CEA gene family member down-regulated in colorectal carcinomas.</title>
<authorList>
<person name="Hauck W."/>
<person name="Nedellec P."/>
<person name="Turbide C."/>
<person name="Stanners C.P."/>
<person name="Barnett T.R."/>
<person name="Beauchemin N."/>
</authorList>
<dbReference type="PubMed" id="8055923"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1994.tb19022.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-21</scope>
<scope>DISEASE</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1995" name="Eur. J. Biochem." volume="231" first="104" last="114">
<title>Characterization and transcriptional activity of the mouse biliary glycoprotein 1 gene, a carcinoembryonic antigen-related gene.</title>
<authorList>
<person name="Nedellec P."/>
<person name="Turbide C."/>
<person name="Beauchemin N."/>
</authorList>
<dbReference type="PubMed" id="7628460"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1995.tb20676.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-21</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1995" name="Oncogene" volume="11" first="1649" last="1655">
<title>Association of pp60c-src with biliary glycoprotein (CD66a), an adhesion molecule of the carcinoembryonic antigen family downregulated in colorectal carcinomas.</title>
<authorList>
<person name="Bruemmer J."/>
<person name="Neumaier M."/>
<person name="Goepfert C."/>
<person name="Wagener C."/>
</authorList>
<dbReference type="PubMed" id="7478590"/>
</citation>
<scope>INTERACTION WITH SRC</scope>
<scope>PHOSPHORYLATION AT TYR-493 AND TYR-520 BY SRC</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1999" name="Exp. Cell Res." volume="252" first="243" last="249">
<title>Redefined nomenclature for members of the carcinoembryonic antigen family.</title>
<authorList>
<person name="Beauchemin N."/>
<person name="Draber P."/>
<person name="Dveksler G."/>
<person name="Gold P."/>
<person name="Gray-Owen S."/>
<person name="Grunert F."/>
<person name="Hammarstrom S."/>
<person name="Holmes K.V."/>
<person name="Karlsson A."/>
<person name="Kuroki M."/>
<person name="Lin S.H."/>
<person name="Lucka L."/>
<person name="Najjar S.M."/>
<person name="Neumaier M."/>
<person name="Obrink B."/>
<person name="Shively J.E."/>
<person name="Skubitz K.M."/>
<person name="Stanners C.P."/>
<person name="Thomas P."/>
<person name="Thompson J.A."/>
<person name="Virji M."/>
<person name="von Kleist S."/>
<person name="Wagener C."/>
<person name="Watt S."/>
<person name="Zimmermann W."/>
</authorList>
<dbReference type="PubMed" id="11501563"/>
<dbReference type="DOI" id="10.1006/excr.1999.4610"/>
</citation>
<scope>NOMENCLATURE OF ALTERNATIVE SPLICING ISOFORMS</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1999" name="Tumor Biol." volume="20" first="277" last="292">
<title>Four carcinoembryonic antigen subfamily members, CEA, NCA, BGP and CGM2, selectively expressed in the normal human colonic epithelium, are integral components of the fuzzy coat.</title>
<authorList>
<person name="Fraengsmyr L."/>
<person name="Baranov V."/>
<person name="Hammarstroem S."/>
</authorList>
<dbReference type="PubMed" id="10436421"/>
<dbReference type="DOI" id="10.1159/000030075"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2000" name="Exp. Cell Res." volume="260" first="365" last="373">
<title>Cell adhesion molecule CEACAM1 associates with paxillin in granulocytes and epithelial and endothelial cells.</title>
<authorList>
<person name="Ebrahimnejad A."/>
<person name="Flayeh R."/>
<person name="Unteregger G."/>
<person name="Wagener C."/>
<person name="Bruemmer J."/>
</authorList>
<dbReference type="PubMed" id="11035932"/>
<dbReference type="DOI" id="10.1006/excr.2000.5026"/>
</citation>
<scope>INTERACTION WITH PXN</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="J. Immunol." volume="168" first="5139" last="5146">
<title>Carcinoembryonic antigen-related cell adhesion molecule 1 expression and signaling in human, mouse, and rat leukocytes: evidence for replacement of the short cytoplasmic domain isoform by glycosylphosphatidylinositol-linked proteins in human leukocytes.</title>
<authorList>
<person name="Singer B.B."/>
<person name="Scheffrahn I."/>
<person name="Heymann R."/>
<person name="Sigmundsson K."/>
<person name="Kammerer R."/>
<person name="Obrink B."/>
</authorList>
<dbReference type="PubMed" id="11994468"/>
<dbReference type="DOI" id="10.4049/jimmunol.168.10.5139"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH CEACAM8</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="50338" last="50345">
<title>CEACAM1, a cell-cell adhesion molecule, directly associates with annexin II in a three-dimensional model of mammary morphogenesis.</title>
<authorList>
<person name="Kirshner J."/>
<person name="Schumann D."/>
<person name="Shively J.E."/>
</authorList>
<dbReference type="PubMed" id="14522961"/>
<dbReference type="DOI" id="10.1074/jbc.m309115200"/>
</citation>
<scope>INTERACTION WITH ANXA2</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS (ISOFORM 8)</scope>
<scope>MUTAGENESIS OF THR-457</scope>
<scope>COMPONENT OF AIIT COMPLEX</scope>
<scope>PHOSPHORYLATION (ISOFORM 8)</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2004" name="J. Clin. Invest." volume="114" first="944" last="952">
<title>CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation.</title>
<authorList>
<person name="Abou-Rjaily G.A."/>
<person name="Lee S.J."/>
<person name="May D."/>
<person name="Al-Share Q.Y."/>
<person name="Deangelis A.M."/>
<person name="Ruch R.J."/>
<person name="Neumaier M."/>
<person name="Kalthoff H."/>
<person name="Lin S.H."/>
<person name="Najjar S.M."/>
</authorList>
<dbReference type="PubMed" id="15467833"/>
<dbReference type="DOI" id="10.1172/jci200421786"/>
</citation>
<scope>PHOSPHORYLATION BY EGFR</scope>
<scope>INTERACTION WITH EGFR</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2005" name="FEBS Lett." volume="579" first="6159" last="6168">
<title>Interactions of DC-SIGN with Mac-1 and CEACAM1 regulate contact between dendritic cells and neutrophils.</title>
<authorList>
<person name="van Gisbergen K.P."/>
<person name="Ludwig I.S."/>
<person name="Geijtenbeek T.B."/>
<person name="van Kooyk Y."/>
</authorList>
<dbReference type="PubMed" id="16246332"/>
<dbReference type="DOI" id="10.1016/j.febslet.2005.09.089"/>
</citation>
<scope>INTERACTION WITH CD209</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2005" name="J. Cell Sci." volume="118" first="5513" last="5524">
<title>CEACAM1 functionally interacts with filamin A and exerts a dual role in the regulation of cell migration.</title>
<authorList>
<person name="Klaile E."/>
<person name="Mueller M.M."/>
<person name="Kannicht C."/>
<person name="Singer B.B."/>
<person name="Lucka L."/>
</authorList>
<dbReference type="PubMed" id="16291724"/>
<dbReference type="DOI" id="10.1242/jcs.02660"/>
</citation>
<scope>INTERACTION WITH FLNA</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2005" name="J. Proteome Res." volume="4" first="2070" last="2080">
<title>Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.</title>
<authorList>
<person name="Liu T."/>
<person name="Qian W.-J."/>
<person name="Gritsenko M.A."/>
<person name="Camp D.G. II"/>
<person name="Monroe M.E."/>
<person name="Moore R.J."/>
<person name="Smith R.D."/>
</authorList>
<dbReference type="PubMed" id="16335952"/>
<dbReference type="DOI" id="10.1021/pr0502065"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-104 AND ASN-111</scope>
<source>
<tissue>Plasma</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="J. Immunol." volume="180" first="6085" last="6093">
<title>Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits proximal TCR signaling by targeting ZAP-70.</title>
<authorList>
<person name="Chen Z."/>
<person name="Chen L."/>
<person name="Qiao S.W."/>
<person name="Nagaishi T."/>
<person name="Blumberg R.S."/>
</authorList>
<dbReference type="PubMed" id="18424730"/>
<dbReference type="DOI" id="10.4049/jimmunol.180.9.6085"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>PHOSPHORYLATION AT TYR-493 AND TYR-520 BY LCK</scope>
<scope>INTERACTION WITH LCK; PTPN6 AND TCR/CD3 COMPLEX</scope>
<scope>MUTAGENESIS OF 77-ARG-GLN-78; TYR-493 AND TYR-520</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-152; ASN-208; ASN-224; ASN-363; ASN-378 AND ASN-405</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2013" name="Eur. J. Immunol." volume="43" first="2473" last="2483">
<title>CEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signaling.</title>
<authorList>
<person name="Hosomi S."/>
<person name="Chen Z."/>
<person name="Baker K."/>
<person name="Chen L."/>
<person name="Huang Y.H."/>
<person name="Olszak T."/>
<person name="Zeissig S."/>
<person name="Wang J.H."/>
<person name="Mandelboim O."/>
<person name="Beauchemin N."/>
<person name="Lanier L.L."/>
<person name="Blumberg R.S."/>
</authorList>
<dbReference type="PubMed" id="23696226"/>
<dbReference type="DOI" id="10.1002/eji.201242676"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH KLRK1 AND PTPN6</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2015" name="Nature" volume="517" first="386" last="390">
<title>CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.</title>
<authorList>
<person name="Huang Y.H."/>
<person name="Zhu C."/>
<person name="Kondo Y."/>
<person name="Anderson A.C."/>
<person name="Gandhi A."/>
<person name="Russell A."/>
<person name="Dougan S.K."/>
<person name="Petersen B.S."/>
<person name="Melum E."/>
<person name="Pertel T."/>
<person name="Clayton K.L."/>
<person name="Raab M."/>
<person name="Chen Q."/>
<person name="Beauchemin N."/>
<person name="Yazaki P.J."/>
<person name="Pyzik M."/>
<person name="Ostrowski M.A."/>
<person name="Glickman J.N."/>
<person name="Rudd C.E."/>
<person name="Ploegh H.L."/>
<person name="Franke A."/>
<person name="Petsko G.A."/>
<person name="Kuchroo V.K."/>
<person name="Blumberg R.S."/>
</authorList>
<dbReference type="PubMed" id="25363763"/>
<dbReference type="DOI" id="10.1038/nature13848"/>
</citation>
<scope>INTERACTION WITH HAVCR2</scope>
<scope>MUTAGENESIS OF ASN-76 AND GLY-81</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2015" name="Proc. Natl. Acad. Sci. U.S.A." volume="112" first="13561" last="13566">
<title>Diverse oligomeric states of CEACAM IgV domains.</title>
<authorList>
<person name="Bonsor D.A."/>
<person name="Gunther S."/>
<person name="Beadenkopf R."/>
<person name="Beckett D."/>
<person name="Sundberg E.J."/>
</authorList>
<dbReference type="PubMed" id="26483485"/>
<dbReference type="DOI" id="10.1073/pnas.1509511112"/>
</citation>
<scope>SUBUNIT</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2006" name="Acta Crystallogr. D" volume="62" first="971" last="979">
<title>Structure of the N-terminal domain of human CEACAM1: binding target of the opacity proteins during invasion of Neisseria meningitidis and N. gonorrhoeae.</title>
<authorList>
<person name="Fedarovich A."/>
<person name="Tomberg J."/>
<person name="Nicholas R.A."/>
<person name="Davies C."/>
</authorList>
<dbReference type="PubMed" id="16929097"/>
<dbReference type="DOI" id="10.1107/s0907444906020737"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 34-141</scope>
</reference>
<comment type="function">
<molecule>Isoform 1</molecule>
<text evidence="2 3 14 16 19 21">Cell adhesion protein that mediates homophilic cell adhesion in a calcium-independent manner (By similarity). Plays a role as coinhibitory receptor in immune response, insulin action and functions also as an activator during angiogenesis (PubMed:18424730, PubMed:23696226, PubMed:25363763). Its coinhibitory receptor function is phosphorylation- and PTPN6 -dependent, which in turn, suppress signal transduction of associated receptors by dephosphorylation of their downstream effectors. Plays a role in immune response, of T cells, natural killer (NK) and neutrophils (PubMed:18424730, PubMed:23696226). Upon TCR/CD3 complex stimulation, inhibits TCR-mediated cytotoxicity by blocking granule exocytosis by mediating homophilic binding to adjacent cells, allowing interaction with and phosphorylation by LCK and interaction with the TCR/CD3 complex which recruits PTPN6 resulting in dephosphorylation of CD247 and ZAP70 (PubMed:18424730). Also inhibits T cell proliferation and cytokine production through inhibition of JNK cascade and plays a crucial role in regulating autoimmunity and anti-tumor immunity by inhibiting T cell through its interaction with HAVCR2 (PubMed:25363763). Upon natural killer (NK) cells activation, inhibit KLRK1-mediated cytolysis of CEACAM1-bearing tumor cells by trans-homophilic interactions with CEACAM1 on the target cell and lead to cis-interaction between CEACAM1 and KLRK1, allowing PTPN6 recruitment and then VAV1 dephosphorylation (PubMed:23696226). Upon neutrophils activation negatively regulates IL1B production by recruiting PTPN6 to a SYK-TLR4-CEACAM1 complex, that dephosphorylates SYK, reducing the production of reactive oxygen species (ROS) and lysosome disruption, which in turn, reduces the activity of the inflammasome. Downregulates neutrophil production by acting as a coinhibitory receptor for CSF3R by downregulating the CSF3R-STAT3 pathway through recruitment of PTPN6 that dephosphorylates CSF3R (By similarity). Also regulates insulin action by promoting INS clearance and regulating lipogenesis in liver through regulating insulin signaling (By similarity). Upon INS stimulation, undergoes phosphorylation by INSR leading to INS clearance by increasing receptor-mediated insulin endocytosis. This inernalization promotes interaction with FASN leading to receptor-mediated insulin degradation and to reduction of FASN activity leading to negative regulation of fatty acid synthesis. INSR-mediated phosphorylation also provokes a down-regulation of cell proliferation through SHC1 interaction resulting in decrease coupling of SHC1 to the MAPK3/ERK1-MAPK1/ERK2 and phosphatidylinositol 3-kinase pathways (By similarity). Functions as activator in angiogenesis by promoting blood vessel remodeling through endothelial cell differentiation and migration and in arteriogenesis by increasing the number of collateral arteries and collateral vessel calibers after ischemia. Also regulates vascular permeability through the VEGFR2 signaling pathway resulting in control of nitric oxide production (By similarity). Downregulates cell growth in response to EGF through its interaction with SHC1 that mediates interaction with EGFR resulting in decrease coupling of SHC1 to the MAPK3/ERK1-MAPK1/ERK2 pathway (By similarity). Negatively regulates platelet aggregation by decreasing platelet adhesion on type I collagen through the GPVI-FcRgamma complex (By similarity). Inhibits cell migration and cell scattering through interaction with FLNA; interfers with the interaction of FLNA with RALA (PubMed:16291724). Mediates bile acid transport activity in a phosphorylation dependent manner (By similarity). Negatively regulates osteoclastogenesis (By similarity).</text>
</comment>
<comment type="function">
<molecule>Isoform 8</molecule>
<text evidence="2 3">Cell adhesion protein that mediates homophilic cell adhesion in a calcium-independent manner (By similarity). Promotes populations of T cells regulating IgA production and secretion associated with control of the commensal microbiota and resistance to enteropathogens (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="2 3 9 10 11 12 13 14 16 19 21 22 23">Monomer. Oligomer. Heterodimer. Homodimer (PubMed:26483485). Cis-dimer/oligomer (via Ig-like C2-type and/or via cytoplasmic domains); induced by trans-homophilic cell adhesion through an allosteric mechanism transmitted by the Ig-like V-type domain, and is regulated by intracellular calcium and calmodulin. Interacts (via cytoplasmic domain) with calmodulin in a calcium dependent manner; reduces homophilic cell adhesion through dissociation of dimer (By similarity). Isoform 1 interacts (via cytoplasmic domain) with PTPN11 (preferentially) and PTPN6; cis-homodimer form is preferred; this interaction is decreased by formation of Isoform 1 /Isoform 8 cis-heterodimers and is dependent on the monomer/dimer equilibrium; this interaction is phosphorylation-dependent (PubMed:23696226). Isoform 1 interacts with LYN (By similarity). Isoform 1 interacts (via cytoplasmic domain) with SRC (via SH2 domain); this interaction is regulated by trans-homophilic cell adhesion (PubMed:7478590). Isoform 1 interacts (via cytoplasmic domain) with LCK; mediates phosphorylation at Tyr-493 and Tyr-520 resulting in PTPN6 association. Isoform 1 interacts with PTPN6; this interaction is phosphorylation-dependent and causes a profound decrease in TCR stimulation-induced CD247 and ZAP70 phosphorylation. Isoform 1 interacts with TCR/CD3 complex through TCR beta chain and CD3E; colocalizes at the cell surface and upon stimulation of the TCR/CD3 complex recruits PTPN6 in the TCR/CD3 complex, resulting in dephosphorylation of CD247 and ZAP70 (PubMed:18424730). Isoform 1 interacts (via cytoplasmic domain) with SHC1 (via SH2 domain); SHC1 mediates interaction with INSR or EGFR in a Ser-508 phosphorylation-dependent manner (By similarity). Isoform 1 interacts with EGFR; the interaction is indirect (PubMed:15467833). Isoform 1 interacts with CSF3R; down-regulates the CSF3R-STAT3 pathway through recruitment of PTPN6 that dephosphorylates CSF3R (By similarity). Isoform 1 (phosphorylated form) interacts with TLR4 and SYK; recruits PTPN6 that dephosphorylates SYK, reducing the production of reactive oxygen species (ROS) and lysosome disruption, leading to a reduction of the inflammasome activity (By similarity). Isoform 1 interacts with FLNA; inhibits cell migration and cell scattering by interfering with the interaction of FLNA with RALA (PubMed:16291724). Isoform 1 interacts (via cytoplasmic domain) with PXN; the interaction is phosphotyrosyl-dependent (PubMed:11035932). Isoform 1 interacts with KLRK1; recruits PTPN6 that dephosphorylates VAV1 (PubMed:23696226). Isoform 1 interacts with CEACAM8 (PubMed:11994468). Isoform 1 interacts with FASN; this interaction is insulin and phosphorylation-dependent; reduces fatty-acid synthase activity (By similarity). Interacts (via Ig-like V-type) with HAVCR2 (via Ig-like V-type); facilitates the maturation and cell surface expression of HAVCR2 thereby regulating T cell tolerance induction (PubMed:25363763). Isoform 8 interacts (via the cytoplasmic domain) with ANXA2; this interaction is regulated by phosphorylation and appears in the AIIt complex (PubMed:14522961). Interacts (via Lewis X moieties) with CD209 (via C-type lectin domain); this interaction is regulated by the glycosylation pattern of CEACAM1 on cell types and regulates contact between dendritic cells and neutrophils (PubMed:16246332).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4314481">
<id>P13688</id>
</interactant>
<interactant intactId="EBI-4314526">
<id>Q16568</id>
<label>CARTPT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4314481">
<id>P13688</id>
</interactant>
<interactant intactId="EBI-4314501">
<id>P40199</id>
<label>CEACAM6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4314481">
<id>P13688</id>
</interactant>
<interactant intactId="EBI-11472922">
<id>Q8TDQ0</id>
<label>HAVCR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4314481">
<id>P13688</id>
</interactant>
<interactant intactId="EBI-7936357">
<id>Q8GH87</id>
<label>uspa1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location evidence="2">Cell membrane</location>
<topology evidence="2">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Lateral cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Apical cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Basal cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="14">Cell junction</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Cell junction</location>
<location evidence="2">Adherens junction</location>
</subcellularLocation>
<text evidence="2">Canalicular domain of hepatocyte plasma membranes. Found as a mixture of monomer, dimer and oligomer in the plasma membrane. Occurs predominantly as cis-dimers and/or small cis-oligomers in the cell junction regions. Found as dimer in the solution. Predominantly localized to the lateral cell membranes.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location evidence="18">Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 3</molecule>
<subcellularLocation>
<location evidence="18">Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 4</molecule>
<subcellularLocation>
<location evidence="18">Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 5</molecule>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 6</molecule>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 7</molecule>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 8</molecule>
<subcellularLocation>
<location evidence="11">Cell membrane</location>
<topology evidence="2">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="11">Cytoplasmic vesicle</location>
<location evidence="11">Secretory vesicle membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Lateral cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Apical cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Basal cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="24">Cell junction</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Cell junction</location>
<location evidence="2">Adherens junction</location>
</subcellularLocation>
<text evidence="2 11">Predominantly localized to the lateral cell membranes. Found as a mixture of monomer, dimer and oligomer in the plasma membrane. Occurs predominantly as cis-dimers and/or small cis-oligomers in the cell junction regions (By similarity). Co-localizes with ANXA2 in secretory vesicles and with S100A10/p11 at the plasma membrane (PubMed:14522961).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Cell projection</location>
<location evidence="3">Microvillus membrane</location>
<topology evidence="35">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="8">Apical cell membrane</location>
<topology evidence="35">Single-pass type I membrane protein</topology>
</subcellularLocation>
<text evidence="3 8">Localized to the apical glycocalyx surface (PubMed:10436421). Colocalizes with CEACAM20 at the apical brush border of intestinal cells.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P13688-1</id>
<name>1</name>
<name>BGPa</name>
<name evidence="26">CEACAM1-4L</name>
<name>TM1-CEA</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P13688-2</id>
<name>2</name>
<name>BGPg</name>
<name evidence="26">CEACAM1-4C1</name>
<sequence type="described" ref="VSP_002482 VSP_002483"/>
</isoform>
<isoform>
<id>P13688-3</id>
<name>3</name>
<name>BGPh</name>
<name evidence="26">CEACAM1-3</name>
<sequence type="described" ref="VSP_002478 VSP_002479"/>
</isoform>
<isoform>
<id>P13688-4</id>
<name>4</name>
<name>BGPi</name>
<name evidence="26">CEACAM1-3C2</name>
<sequence type="described" ref="VSP_002480 VSP_002481"/>
</isoform>
<isoform>
<id>P13688-5</id>
<name>5</name>
<name>BGPy</name>
<name evidence="26">CEACAM1-3AL</name>
<sequence type="described" ref="VSP_009227"/>
</isoform>
<isoform>
<id>P13688-6</id>
<name>6</name>
<name>BGPb</name>
<name evidence="26">CEACAM1-3L</name>
<name>TM2-CEA</name>
<sequence type="described" ref="VSP_010938"/>
</isoform>
<isoform>
<id>P13688-7</id>
<name>7</name>
<name>BGPx</name>
<name evidence="26">CEACAM1-1L</name>
<sequence type="described" ref="VSP_012222"/>
</isoform>
<isoform>
<id>P13688-8</id>
<name>8</name>
<name>BGPc</name>
<name evidence="26">CEACAM1-4S</name>
<name>TM3-CEA</name>
<sequence type="described" ref="VSP_040572 VSP_040574"/>
</isoform>
<isoform>
<id>P13688-9</id>
<name>9</name>
<name>BGPz</name>
<name>CEACAM1-3AS</name>
<sequence type="described" ref="VSP_040571 VSP_040572 VSP_040574"/>
</isoform>
<isoform>
<id>P13688-10</id>
<name>10</name>
<sequence type="described" ref="VSP_040573 VSP_040575"/>
</isoform>
<isoform>
<id>P13688-11</id>
<name>11</name>
<name>BGPd</name>
<name>CEACAM1-3S</name>
<sequence type="described" ref="VSP_010938 VSP_040572 VSP_040574"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="8 10 16">Expressed in columnar epithelial cells of the colon (at protein level) (PubMed:10436421). The predominant forms expressed by T cells are those containing a long cytoplasmic domain (PubMed:18424730). Expressed in granulocytes and lymphocytes. Leukocytes only express isoforms 6 and isoform 1 (PubMed:11994468).</text>
</comment>
<comment type="induction">
<text evidence="16">Induced in primary T cells by activation with IL-2.</text>
</comment>
<comment type="domain">
<text evidence="2">Ig-like V-type domain mediates trans-homophilic cell adhesion through homodimerization and this active process is regulated by tyrosine kinase, PTPN11 AND PTPN6. Ig-like C2-type and/or cytoplasmic domains mediate cis-dimer/oligomer.</text>
</comment>
<comment type="PTM">
<molecule>Isoform 1</molecule>
<text evidence="2 3 12 16 23">Phosphorylated on serine and tyrosine (By similarity). Isoform 1 is phosphorylated on tyrosine by Src family kinases like SRC and LCK and by receptor like CSF3R, EGFR and INSR upon stimulation (PubMed:15467833, PubMed:18424730, PubMed:7478590). Phosphorylated at Ser-508; mediates activity. Phosphorylated at Tyr-493; regulates activity (By similarity). Phosphorylated at Tyr-493 by EGFR and INSR upon stimulation; this phosphorylation is Ser-508-phosphorylation-dependent; mediates cellular internalization; increases interaction with downstream proteins like SHC1 and FASN (By similarity). Phosphorylated at Tyr-493 and Tyr-520 by LCK; mediates PTPN6 association and is regulated by homophilic ligation of CEACAM1 in the absence of T cell activation (PubMed:18424730). Phosphorylated at Tyr-520; mediates interaction with PTPN11 (By similarity).</text>
</comment>
<comment type="PTM">
<molecule>Isoform 8</molecule>
<text evidence="11">Phosphorylated on serine and threonine.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 8</molecule>
<text evidence="11">Pseudophosphorylated double mutant Thr-457-&gt;Asp and Ser-459-&gt;Asp. The single mutant Ser-459-&gt;Asp mutant highly binds with ANXA2.</text>
</comment>
<comment type="similarity">
<text evidence="35">Belongs to the immunoglobulin superfamily. CEA family.</text>
</comment>
<comment type="sequence caution" evidence="35">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="AAA57141" version="1"/>
</conflict>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/ceacam1/"/>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/CEACAM1ID40044ch19q13.html"/>
</comment>
<dbReference type="EMBL" id="J03858">
<property type="protein sequence ID" value="AAA51826.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X14831">
<property type="protein sequence ID" value="CAA32940.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X16354">
<property type="protein sequence ID" value="CAA34404.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X16356">
<property type="protein sequence ID" value="CAA34405.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D90311">
<property type="protein sequence ID" value="BAA14341.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D90312">
<property type="protein sequence ID" value="BAA14342.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D90313">
<property type="protein sequence ID" value="BAA14343.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M69176">
<property type="protein sequence ID" value="AAA51825.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M72238">
<property type="protein sequence ID" value="AAA58393.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M72238">
<property type="protein sequence ID" value="AAA58394.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M76741">
<property type="protein sequence ID" value="AAA57141.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M76742">
<property type="protein sequence ID" value="AAA57142.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M76743">
<property type="protein sequence ID" value="AAA57143.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M76744">
<property type="protein sequence ID" value="AAA57144.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S71326">
<property type="protein sequence ID" value="AAB31183.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D12502">
<property type="protein sequence ID" value="BAA02063.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY766113">
<property type="protein sequence ID" value="AAV34600.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ989182">
<property type="protein sequence ID" value="ABI75349.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004785">
<property type="protein sequence ID" value="AAC18433.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004785">
<property type="protein sequence ID" value="AAC18434.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004785">
<property type="protein sequence ID" value="AAC18435.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004785">
<property type="protein sequence ID" value="AAC18436.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004785">
<property type="protein sequence ID" value="AAC18437.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004785">
<property type="protein sequence ID" value="AAC18438.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004785">
<property type="protein sequence ID" value="AAC18439.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471126">
<property type="protein sequence ID" value="EAW57137.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471126">
<property type="protein sequence ID" value="EAW57140.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471126">
<property type="protein sequence ID" value="EAW57141.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471126">
<property type="protein sequence ID" value="EAW57143.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014473">
<property type="protein sequence ID" value="AAH14473.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X67277">
<property type="protein sequence ID" value="CAA47694.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12609.1">
<molecule id="P13688-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS46089.1">
<molecule id="P13688-8"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54272.1">
<molecule id="P13688-11"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54273.1">
<molecule id="P13688-6"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54274.1">
<molecule id="P13688-5"/>
</dbReference>
<dbReference type="PIR" id="A32164">
<property type="entry name" value="A32164"/>
</dbReference>
<dbReference type="PIR" id="B48078">
<property type="entry name" value="B48078"/>
</dbReference>
<dbReference type="PIR" id="JH0394">
<property type="entry name" value="JH0394"/>
</dbReference>
<dbReference type="PIR" id="JH0395">
<property type="entry name" value="JH0395"/>
</dbReference>
<dbReference type="PIR" id="JH0396">
<property type="entry name" value="JH0396"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001020083.1">
<molecule id="P13688-8"/>
<property type="nucleotide sequence ID" value="NM_001024912.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001171742.1">
<molecule id="P13688-6"/>
<property type="nucleotide sequence ID" value="NM_001184813.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001171744.1">
<molecule id="P13688-5"/>
<property type="nucleotide sequence ID" value="NM_001184815.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001171745.1">
<molecule id="P13688-11"/>
<property type="nucleotide sequence ID" value="NM_001184816.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001192273.1">
<molecule id="P13688-10"/>
<property type="nucleotide sequence ID" value="NM_001205344.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001703.2">
<molecule id="P13688-1"/>
<property type="nucleotide sequence ID" value="NM_001712.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011525508.1">
<molecule id="P13688-4"/>
<property type="nucleotide sequence ID" value="XM_011527206.1"/>
</dbReference>
<dbReference type="PDB" id="2GK2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=34-141"/>
</dbReference>
<dbReference type="PDB" id="4QXW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.04"/>
<property type="chains" value="A/B=35-141"/>
</dbReference>
<dbReference type="PDB" id="4WHD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=34-141"/>
</dbReference>
<dbReference type="PDB" id="5DZL">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A/B/C/D=35-141"/>
</dbReference>
<dbReference type="PDB" id="6AW2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.68"/>
<property type="chains" value="A=34-141"/>
</dbReference>
<dbReference type="PDB" id="6GBG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="D=35-142"/>
</dbReference>
<dbReference type="PDB" id="6GBH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.59"/>
<property type="chains" value="B/D=35-142"/>
</dbReference>
<dbReference type="PDBsum" id="2GK2"/>
<dbReference type="PDBsum" id="4QXW"/>
<dbReference type="PDBsum" id="4WHD"/>
<dbReference type="PDBsum" id="5DZL"/>
<dbReference type="PDBsum" id="6AW2"/>
<dbReference type="PDBsum" id="6GBG"/>
<dbReference type="PDBsum" id="6GBH"/>
<dbReference type="SMR" id="P13688"/>
<dbReference type="BioGRID" id="107103">
<property type="interactions" value="12"/>
</dbReference>
<dbReference type="DIP" id="DIP-42683N"/>
<dbReference type="IntAct" id="P13688">
<property type="interactions" value="8"/>
</dbReference>
<dbReference type="MINT" id="P13688"/>
<dbReference type="STRING" id="9606.ENSP00000161559"/>
<dbReference type="DrugBank" id="DB00113">
<property type="generic name" value="Technetium Tc-99m arcitumomab"/>
</dbReference>
<dbReference type="GlyConnect" id="1070">
<property type="glycosylation" value="14 N-Linked glycans (5 sites)"/>
</dbReference>
<dbReference type="GlyConnect" id="1072">
<property type="glycosylation" value="5 N-Linked glycans (2 sites)"/>
</dbReference>
<dbReference type="GlyGen" id="P13688">
<property type="glycosylation" value="23 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P13688"/>
<dbReference type="PhosphoSitePlus" id="P13688"/>
<dbReference type="BioMuta" id="CEACAM1"/>
<dbReference type="DMDM" id="399116"/>
<dbReference type="CPTAC" id="CPTAC-1179"/>
<dbReference type="jPOST" id="P13688"/>
<dbReference type="MassIVE" id="P13688"/>
<dbReference type="MaxQB" id="P13688"/>
<dbReference type="PaxDb" id="P13688"/>
<dbReference type="PeptideAtlas" id="P13688"/>
<dbReference type="PRIDE" id="P13688"/>
<dbReference type="ProteomicsDB" id="52961">
<molecule id="P13688-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52962">
<molecule id="P13688-10"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52963">
<molecule id="P13688-11"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52964">
<molecule id="P13688-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52965">
<molecule id="P13688-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52966">
<molecule id="P13688-4"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52967">
<molecule id="P13688-5"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52968">
<molecule id="P13688-6"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52969">
<molecule id="P13688-7"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52970">
<molecule id="P13688-8"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52971">
<molecule id="P13688-9"/>
</dbReference>
<dbReference type="TopDownProteomics" id="P13688-2">
<molecule id="P13688-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="3684">
<property type="antibodies" value="902 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="634"/>
<dbReference type="Ensembl" id="ENST00000161559">
<molecule id="P13688-1"/>
<property type="protein sequence ID" value="ENSP00000161559"/>
<property type="gene ID" value="ENSG00000079385"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000352591">
<molecule id="P13688-6"/>
<property type="protein sequence ID" value="ENSP00000244291"/>
<property type="gene ID" value="ENSG00000079385"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000358394">
<molecule id="P13688-5"/>
<property type="protein sequence ID" value="ENSP00000351165"/>
<property type="gene ID" value="ENSG00000079385"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000403444">
<molecule id="P13688-8"/>
<property type="protein sequence ID" value="ENSP00000384709"/>
<property type="gene ID" value="ENSG00000079385"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000403461">
<molecule id="P13688-11"/>
<property type="protein sequence ID" value="ENSP00000384083"/>
<property type="gene ID" value="ENSG00000079385"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000599389">
<molecule id="P13688-9"/>
<property type="protein sequence ID" value="ENSP00000471918"/>
<property type="gene ID" value="ENSG00000079385"/>
</dbReference>
<dbReference type="GeneID" id="634"/>
<dbReference type="KEGG" id="hsa:634"/>
<dbReference type="UCSC" id="uc002otv.3">
<molecule id="P13688-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="634"/>
<dbReference type="DisGeNET" id="634"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000079385.21"/>
<dbReference type="GeneCards" id="CEACAM1"/>
<dbReference type="HGNC" id="HGNC:1814">
<property type="gene designation" value="CEACAM1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000079385">
<property type="expression patterns" value="Tissue enhanced (intestine, liver, lymphoid tissue)"/>
</dbReference>
<dbReference type="MIM" id="109770">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P13688"/>
<dbReference type="OpenTargets" id="ENSG00000079385"/>
<dbReference type="PharmGKB" id="PA26358"/>
<dbReference type="eggNOG" id="ENOG502RXPD">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00960000186634"/>
<dbReference type="HOGENOM" id="CLU_024555_2_0_1"/>
<dbReference type="InParanoid" id="P13688"/>
<dbReference type="KO" id="K06499"/>
<dbReference type="OMA" id="NTSYLWS"/>
<dbReference type="OrthoDB" id="998214at2759"/>
<dbReference type="PhylomeDB" id="P13688"/>
<dbReference type="TreeFam" id="TF336859"/>
<dbReference type="PathwayCommons" id="P13688"/>
<dbReference type="Reactome" id="R-HSA-1566977">
<property type="pathway name" value="Fibronectin matrix formation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202733">
<property type="pathway name" value="Cell surface interactions at the vascular wall"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6798695">
<property type="pathway name" value="Neutrophil degranulation"/>
</dbReference>
<dbReference type="SIGNOR" id="P13688"/>
<dbReference type="BioGRID-ORCS" id="634">
<property type="hits" value="5 hits in 874 CRISPR screens"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P13688"/>
<dbReference type="GeneWiki" id="CEACAM1"/>
<dbReference type="GenomeRNAi" id="634"/>
<dbReference type="Pharos" id="P13688">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P13688"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="P13688">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000079385">
<property type="expression patterns" value="Expressed in colonic mucosa and 175 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P13688">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P13688">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005912">
<property type="term" value="C:adherens junction"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009925">
<property type="term" value="C:basal plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030054">
<property type="term" value="C:cell junction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005911">
<property type="term" value="C:cell-cell junction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016328">
<property type="term" value="C:lateral plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0031528">
<property type="term" value="C:microvillus membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035579">
<property type="term" value="C:specific granule membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070821">
<property type="term" value="C:tertiary granule membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030658">
<property type="term" value="C:transport vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0003779">
<property type="term" value="F:actin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015125">
<property type="term" value="F:bile acid transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005516">
<property type="term" value="F:calmodulin binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031005">
<property type="term" value="F:filamin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019900">
<property type="term" value="F:kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046983">
<property type="term" value="F:protein dimerization activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019903">
<property type="term" value="F:protein phosphatase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990782">
<property type="term" value="F:protein tyrosine kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015721">
<property type="term" value="P:bile acid and bile salt transport"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001568">
<property type="term" value="P:blood vessel development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007155">
<property type="term" value="P:cell adhesion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016477">
<property type="term" value="P:cell migration"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098742">
<property type="term" value="P:cell-cell adhesion via plasma-membrane adhesion molecules"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032869">
<property type="term" value="P:cellular response to insulin stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035726">
<property type="term" value="P:common myeloid progenitor cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038158">
<property type="term" value="P:granulocyte colony-stimulating factor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007156">
<property type="term" value="P:homophilic cell adhesion via plasma membrane adhesion molecules"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901143">
<property type="term" value="P:insulin catabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038016">
<property type="term" value="P:insulin receptor internalization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007229">
<property type="term" value="P:integrin-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050900">
<property type="term" value="P:leukocyte migration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043318">
<property type="term" value="P:negative regulation of cytotoxic T cell degranulation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045717">
<property type="term" value="P:negative regulation of fatty acid biosynthetic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030853">
<property type="term" value="P:negative regulation of granulocyte differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000346">
<property type="term" value="P:negative regulation of hepatocyte proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032692">
<property type="term" value="P:negative regulation of interleukin-1 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051055">
<property type="term" value="P:negative regulation of lipid biosynthetic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002859">
<property type="term" value="P:negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090331">
<property type="term" value="P:negative regulation of platelet aggregation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006469">
<property type="term" value="P:negative regulation of protein kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001915">
<property type="term" value="P:negative regulation of T cell mediated cytotoxicity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050860">
<property type="term" value="P:negative regulation of T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043116">
<property type="term" value="P:negative regulation of vascular permeability"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043312">
<property type="term" value="P:neutrophil degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:2001214">
<property type="term" value="P:positive regulation of vasculogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060312">
<property type="term" value="P:regulation of blood vessel remodeling"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001558">
<property type="term" value="P:regulation of cell growth"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030334">
<property type="term" value="P:regulation of cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045601">
<property type="term" value="P:regulation of endothelial cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010594">
<property type="term" value="P:regulation of endothelial cell migration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042058">
<property type="term" value="P:regulation of epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070372">
<property type="term" value="P:regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903385">
<property type="term" value="P:regulation of homophilic cell adhesion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014066">
<property type="term" value="P:regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903670">
<property type="term" value="P:regulation of sprouting angiogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044319">
<property type="term" value="P:wound healing, spreading of cells"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="4"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR013106">
<property type="entry name" value="Ig_V-set"/>
</dbReference>
<dbReference type="InterPro" id="IPR013151">
<property type="entry name" value="Immunoglobulin"/>
</dbReference>
<dbReference type="Pfam" id="PF00047">
<property type="entry name" value="ig"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13895">
<property type="entry name" value="Ig_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07686">
<property type="entry name" value="V-set"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="3"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0873">Pyrrolidone carboxylic acid</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide">
<location>
<begin position="1"/>
<end position="34"/>
</location>
</feature>
<feature type="chain" description="Carcinoembryonic antigen-related cell adhesion molecule 1" id="PRO_0000014562">
<location>
<begin position="35"/>
<end position="526"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="5">
<location>
<begin position="35"/>
<end position="428"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="5">
<location>
<begin position="429"/>
<end position="452"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="5">
<location>
<begin position="453"/>
<end position="526"/>
</location>
</feature>
<feature type="domain" description="Ig-like V-type" evidence="4">
<location>
<begin position="35"/>
<end position="142"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1" evidence="6">
<location>
<begin position="145"/>
<end position="232"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2" evidence="6">
<location>
<begin position="237"/>
<end position="317"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3" evidence="6">
<location>
<begin position="323"/>
<end position="413"/>
</location>
</feature>
<feature type="region of interest" description="Required for homophilic binding" evidence="2">
<location>
<begin position="39"/>
<end position="142"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with calmodulin" evidence="2">
<location>
<begin position="450"/>
<end position="462"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with FLNA" evidence="2">
<location>
<begin position="452"/>
<end position="526"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with PTPN11 and PTPN6 and for control of phosphorylation level" evidence="3">
<location>
<begin position="489"/>
<end position="526"/>
</location>
</feature>
<feature type="region of interest" description="Essential for interaction with PTPN11 and PTPN6" evidence="3">
<location>
<begin position="520"/>
<end position="523"/>
</location>
</feature>
<feature type="modified residue" description="Pyrrolidone carboxylic acid" evidence="20">
<location>
<position position="35"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SRC, LCK, INSR and EGFR" evidence="16 23">
<location>
<position position="493"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="508"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by INSR, SRC and LCK" evidence="16 23">
<location>
<position position="520"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 15">
<location>
<position position="104"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 15">
<location>
<position position="111"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="115"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 17">
<location>
<position position="152"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="182"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="197"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 17">
<location>
<position position="208"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 17">
<location>
<position position="224"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="232"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="254"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="274"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="288"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="292"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="302"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="309"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="345"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="351"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 17">
<location>
<position position="363"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 17">
<location>
<position position="378"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 17">
<location>
<position position="405"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="167"/>
<end position="215"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="259"/>
<end position="299"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 6">
<location>
<begin position="348"/>
<end position="396"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7." id="VSP_012222" evidence="32">
<location>
<begin position="143"/>
<end position="416"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6 and isoform 11." id="VSP_010938" evidence="29 34">
<original>ELSPVVAKPQIKASKTTVTGDKDSVNLTCSTNDTGISIRWFFKNQSLPSSERMKLSQGNTTLSINPVKREDAGTYWCEVFNPISKNQSDPIMLNVNY</original>
<variation>D</variation>
<location>
<begin position="320"/>
<end position="416"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_002478" evidence="28">
<original>EL</original>
<variation>GK</variation>
<location>
<begin position="320"/>
<end position="321"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_009227" evidence="32 33">
<original>LSPVVAKPQIKASKTTVTGDKDSVNLTCSTNDTGISIRWFFKNQSLPSSERMKLSQGNTTLSINPVKREDAGTYWCEVFNPISKNQSDPIMLNVNY</original>
<variation>RQNLTMLPRLDSNSWAQAILPSVSQSAEITD</variation>
<location>
<begin position="321"/>
<end position="416"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 9." id="VSP_040571" evidence="32">
<original>LSPVVAKPQIKASKTTVTGDKDSVNLTCSTNDTGISIRWFFKNQSLPSSERMKLSQGNTTLSINPVKREDAGTYWCEVFNPISKNQSDPIMLNVNY</original>
<variation>MAFHHVAKAGLKLLSSSNPPASTSQSAKITD</variation>
<location>
<begin position="321"/>
<end position="416"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_002480" evidence="28">
<original>LSPVVAKPQIKASKTTVTGDKDSVNLTCSTN</original>
<variation>SPVLGEDEAVPGQHHPQHKPCQEGGCWDVLV</variation>
<location>
<begin position="321"/>
<end position="351"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_002479" evidence="28">
<location>
<begin position="322"/>
<end position="526"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_002481" evidence="28">
<location>
<begin position="352"/>
<end position="526"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_002482" evidence="28">
<original>YN</original>
<variation>CK</variation>
<location>
<begin position="416"/>
<end position="417"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_002483" evidence="28">
<location>
<begin position="418"/>
<end position="526"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 8, isoform 9 and isoform 11." id="VSP_040572" evidence="29 31 32 34">
<original>RASDQR</original>
<variation>SSGPLQ</variation>
<location>
<begin position="459"/>
<end position="464"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 10." id="VSP_040573" evidence="27">
<original>ASDQRDLTE</original>
<variation>TTPMTHLTR</variation>
<location>
<begin position="460"/>
<end position="468"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 8, isoform 9 and isoform 11." id="VSP_040574" evidence="29 31 32 34">
<location>
<begin position="465"/>
<end position="526"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 10." id="VSP_040575" evidence="27">
<location>
<begin position="469"/>
<end position="526"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs8111171." id="VAR_049844" evidence="25">
<original>Q</original>
<variation>K</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs8110904." id="VAR_049845" evidence="25">
<original>A</original>
<variation>V</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs8111468." id="VAR_049846" evidence="25">
<original>Q</original>
<variation>H</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41355544." id="VAR_049847" evidence="25">
<original>Q</original>
<variation>R</variation>
<location>
<position position="376"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with HAVCR2." evidence="21">
<original>N</original>
<variation>A</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="mutagenesis site" description="Doesn't affect cell surface expression. Impairs phosphorylation." evidence="16">
<original>RQ</original>
<variation>GL</variation>
<location>
<begin position="77"/>
<end position="78"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with HAVCR2." evidence="21">
<original>G</original>
<variation>A</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases the binding to ANXA2." evidence="11">
<original>T</original>
<variation>D</variation>
<location>
<position position="457"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs phosphorylation; when associated with F-520." evidence="16">
<original>Y</original>
<variation>F</variation>
<location>
<position position="493"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs phosphorylation; when associated with F-493." evidence="16">
<original>Y</original>
<variation>F</variation>
<location>
<position position="520"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAA57142." ref="6" evidence="35">
<original>P</original>
<variation>H</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAA02063." ref="5" evidence="35">
<original>D</original>
<variation>Y</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="37"/>
<end position="46"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="51"/>
<end position="56"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="60"/>
<end position="73"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="75"/>
<end position="77"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="78"/>
<end position="83"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="84"/>
<end position="87"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="88"/>
<end position="91"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="99"/>
<end position="101"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="107"/>
<end position="109"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="114"/>
<end position="116"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="118"/>
<end position="126"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="132"/>
<end position="141"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAA57143." ref="6" evidence="35">
<original>N</original>
<variation>L</variation>
<location sequence="P13688-5">
<position position="323"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAA02063." ref="5" evidence="35">
<original>R</original>
<variation>G</variation>
<location sequence="P13688-5">
<position position="329"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAA57143." ref="6" evidence="35">
<original>Q</original>
<variation>E</variation>
<location sequence="P13688-5">
<position position="337"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4QXW"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P16573"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P31809"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P31997"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255"/>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00498"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10436421"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11035932"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11994468"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14522961"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15467833"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16246332"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16291724"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16335952"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18424730"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2025273"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23696226"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2457922"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25363763"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26483485"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7478590"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8018919"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source ref="9"/>
</evidence>
<evidence key="26" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11501563"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2025273"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2537311"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7628460"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8018919"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8423792"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000303">
<source ref="5"/>
</evidence>
<evidence key="34" type="ECO:0000303">
<source ref="8"/>
</evidence>
<evidence key="35" type="ECO:0000305"/>
<evidence key="36" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:1814"/>
</source>
</evidence>
<sequence length="526" mass="57560" checksum="CAD1B2328D069AF8" modified="1993-07-01" version="2" precursor="true">MGHLSAPLHRVRVPWQGLLLTASLLTFWNPPTTAQLTTESMPFNVAEGKEVLLLVHNLPQQLFGYSWYKGERVDGNRQIVGYAIGTQQATPGPANSGRETIYPNASLLIQNVTQNDTGFYTLQVIKSDLVNEEATGQFHVYPELPKPSISSNNSNPVEDKDAVAFTCEPETQDTTYLWWINNQSLPVSPRLQLSNGNRTLTLLSVTRNDTGPYECEIQNPVSANRSDPVTLNVTYGPDTPTISPSDTYYRPGANLSLSCYAASNPPAQYSWLINGTFQQSTQELFIPNITVNNSGSYTCHANNSVTGCNRTTVKTIIVTELSPVVAKPQIKASKTTVTGDKDSVNLTCSTNDTGISIRWFFKNQSLPSSERMKLSQGNTTLSINPVKREDAGTYWCEVFNPISKNQSDPIMLNVNYNALPQENGLSPGAIAGIVIGVVALVALIAVALACFLHFGKTGRASDQRDLTEHKPSVSNHTQDHSNDPPNKMNEVTYSTLNFEAQQPTQPTSASPSLTATEIIYSEVKKQ</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

